Skip to main content

Table 3 miRs prediction of patients with high Grade vs No-Cancer + Low Grade tumors in Validation cohort 2

From: A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients

  Validation cohort 2
High Grade vs No-Cancer + Low-grade
Variables Univariate   Multivariate  
  Odds ratio (CI) p Odds ratio (CI) p
AGE 1.10(1.01–1.19) .027 1.09(0.98–1.20) .10
PSA 1.07(0.99–1.15) .68   
miR-26b-5p .015(.000–.60) .25 .018(.001–.85) .041
miR-30c .97(.90–1.04) .34   
miR-21-5p .99(.98–1.01) .34   
miR-98-5p .62(0.27–1.44) .62   
miR-4732-3p 1.65(1.09–2.50) .018 1.4(.87–2.27) .17
Let7a-5p .99(.97–1.01) .40   
  1. Abbreviations: CI Confident Interval, p p value, PSA Prostate Specific Antigen. Data are presented as odds ratio (CI). Empty cells correspond to variables that were not measured. Baseline variables that achieved a level of significance of p < .05 in the univariate analysis were entered into multivariate models